Englewood, Colorado-based biopharmaceutical firm, Ampio Pharmaceuticals, Inc., has announced its continued pursuit of developing treatments for pain related to osteoarthritis. Specifically, the company is directing its efforts toward the preclinical development of a proprietary small molecule formulation, AR-300, which targets osteoarthritis of the knee.
Ampio Pharmaceuticals's ticker is AMPE
The company's shares trade on the NYSE stock exchange
They are based in Englewood, Colorado
There are 11-50 employees working at Ampio Pharmaceuticals
It is http://ampiopharma.com/
Ampio Pharmaceuticals is in the Healthcare sector
Ampio Pharmaceuticals is in the Biotechnology industry
The following five companies are Ampio Pharmaceuticals's industry peers: